Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SLUGging away at cell death.

Michael W Becker1, Michael F Clarke

  • 1Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.

Cancer Cell
|October 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.

bioRxiv : the preprint server for biology·2026
Same author

CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia.

Neoplasia (New York, N.Y.)·2026
Same author

The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemia.

Blood neoplasia·2026
Same author

Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapse.

Leukemia·2025
Same author

Elevated lactate in AML bone marrow contributes to macrophage polarization via GPR81 signaling.

Blood advances·2025
Same author

PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AML.

bioRxiv : the preprint server for biology·2025
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

Programmed cell death (PCD) is crucial in blood cell development and cancer. A study shows Slug, a CED-1 homolog, regulates apoptosis in hematopoietic progenitors after gamma radiation exposure.

Area of Science:

  • Hematopoiesis research
  • Cell death mechanisms
  • Cancer biology

Background:

  • Programmed cell death (PCD) is vital for normal and malignant hematopoiesis.
  • Understanding apoptosis regulation in hematopoietic stem cells is critical for cancer therapy.

Purpose of the Study:

  • To investigate the role of CED-1 homolog, Slug, in apoptosis of hematopoietic progenitors.
  • To elucidate the molecular mechanisms underlying radiation-induced cell death in early blood cell development.

Main Methods:

  • Utilized gene homology analysis to identify potential regulators.
  • Examined the function of Slug in response to gamma radiation.
  • Assessed apoptosis in hematopoietic progenitor cells.

Main Results:

Related Experiment Videos

  • Demonstrated that Slug acts as a key regulator of apoptosis.
  • Showcased Slug's involvement in the response of early hematopoietic progenitors to gamma radiation.

Conclusions:

  • Slug is a critical mediator of apoptosis in hematopoietic progenitor cells following radiation.
  • Findings provide insights into PCD regulation in hematopoiesis and potential therapeutic targets.